Congratulations to Dr. David Vocadlo on being named a Fellow in the Royal Society of Canada, Canada’s highest academic honour.
Tag: GlycoNet
New study yields significant insight into a major driver of Alzheimer’s Disease
GlycoNet researchers find that CD33 isoforms on the surface of the brain’s microglia can have opposing effects, providing protection or increased susceptibility to Alzheimer’s Disease.
Sugar-blocking technology “supercharges” antibodies to fight cancer
GlycoNet investigators have created a much faster and simpler method of producing therapeutic antibodies that could help target different types of cancer.
Takeaways from the 7th Canadian Glycomics Symposium & 10th Warren Workshop
The 2024 Canadian Glycomics Symposium & Warren Workshop brought together over 140 leading researchers, industry experts, and participants worldwide to explore cutting-edge advancements in the field of glycomics.
Shaping a new era in health and sustainability with glycomics
In the most recent issue of BIOTECanada’s Insights Magazine, we talk about how the field of glycomics (the study of sugars) is yielding new solutions in health and sustainability.
New Investments in Global-leading, Alberta-based Genomics Technology Platforms to Advance Services
Genome Canada and Genome Alberta recently announced an investment of $1M in GlycoNet Integrated Services (GIS) to develop and expand glycomics services with applications in health, agriculture and bio-based industries.
GlycoNet and NOVA School of Science and Technology (NOVA FCT) sign MOU to collaborate and advance the next frontier of bioinnovation
GlycoNet and NOVA School of Science and Technology (NOVA FCT) sign MOU to collaborate and advance the next frontier of bioinnovation
GlycoNet investigators identify a cancer-associated sugar as a new biomarker for scleroderma
A sugar that’s been linked to cancer could also serve as an early indicator of severe scleroderma, improving diagnosis and treatment options for patients with this rare disease.
The Carbohydrate Connection: Finding a Way to Target Alzheimer’s
GlycoNet Investigator Dr. Matthew Macauley is uncovering how carbohydrates influence immune cells in the brain and their impact on Alzheimer’s disease.
Strategic Science Fund Announcement
GlycoNet is grateful to be one of the inaugural recipients of the Strategic Science Fund.